Cytori Therapeutics, Inc. (NASDAQ: CYTX) presented data from two preclinical studies funded through its contract with the United States Biomedical ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Management Comments

Cytori Therapeutics (CYTX) a Step Closer to Clinical Trials, Maxim Group NotesApril 23, 2015 12:25 PM Cytori Reports Preclinical and Mechanistic Data Supporting Use of Cytori Cell Therapy in Wounds Combining Thermal Burn and Radiation ExposureApril 23, 2015 8:01 AM